v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (2,157,341) $ (2,424,348)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation-fair value of vested stock options 35,183 210,684
Change in fair value of warrant liability (505) (3,469)
Changes in operating assets and liabilities:    
Advances on research and development contract services 37,773
Prepaid insurance 169,201 196,750
Interest receivable 918
Accounts payable and accrued expenses 97,547 6,222
Net cash used in operating activities (1,854,997) (1,976,388)
Cash flows from financing activities    
Proceeds from issuance of common shares from ATM, net of costs 20,180 347,549
Proceeds from sale of common stock, pre-funded warrants and warrants in public offering, net of offering costs 4,352,792
Proceeds from sale of pre-funded warrants and warrants in private placement, net of offering costs 2,639,667
Exercise of pre-funded warrants 1,579
Deferred offering costs (52,666)
Net cash provided by financing activities 2,608,760 4,700,341
Net increase in cash 753,763 2,723,953
Cash, beginning of period 5,334,322 3,325,131
Cash, end of period 6,088,085 6,049,084
Supplemental information    
Income taxes paid
Noncash investing and financing activities    
Options issued to settle accrued bonus $ 34,854 $ 46,183